TD Cowen Defending Dianthus Therapeutics (DNTH): 'We see weakness as a buying opportunity' Jun 10, 2026 01:37PM
Dianthus Therapeutics completes $719 million public offering Mar 12, 2026 04:01PM
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Mar 12, 2026 04:01PM
Dianthus Therapeutics prices $625 million public stock offering Mar 10, 2026 10:54PM
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering Mar 10, 2026 10:54PM


Mar 9, 2026 04:01PM Dianthus Therapeutics announces $400 million public stock offering
Mar 9, 2026 04:01PM Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
Mar 9, 2026 11:49AM TD Cowen Reiterates Buy Rating on Dianthus Therapeutics (DNTH): "prime takeout target"
Feb 24, 2026 07:00AM Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
Nov 4, 2025 08:00AM Dianthus Therapeutics to Participate in Four Investor Conferences During November
Oct 16, 2025 09:57AM TD Cowen on Dianthus (DNTH): 'the favorable economics of the deal will not impact prior guidance of cash runway into 2028'
Sep 11, 2025 04:07PM Dianthus Therapeutics closes $288 million public offering
Sep 11, 2025 04:07PM Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 9, 2025 10:35PM Dianthus Therapeutics prices $251 million public offering at $33 per share
Sep 9, 2025 10:35PM Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering
Sep 8, 2025 04:00PM Dianthus Therapeutics announces $150 million public offering
Sep 8, 2025 04:00PM Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
Feb 26, 2025 07:00AM Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences
Dec 20, 2024 05:31AM TD Cowen Starts Dianthus Therapeutics (DNTH) at Buy